NeoGenomics Inc (NEO) financials · rev $727.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
NeoGenomics Inc (NEO) rev $727.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $727.3M | $660.6M |
| Cost of Revenue | $413.0M | $370.5M |
| Gross Profit | $314.3M | $290.1M |
| Operating Income | -$115.9M | -$92.1M |
| Net Income | -$108.0M | -$78.7M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.36B | $1.64B |
| Current Assets | $376.3M | $596.0M |
| Cash & Equivalents | $159.6M | $367.0M |
| Inventory | $28.6M | $26.7M |
| PP&E | $84.8M | $94.1M |
| Total Liabilities | $523.3M | $735.7M |
| Current Liabilities | $88.3M | $301.2M |
| Short-term Debt | N/A | $200.8M |
| Long-term Debt | $341.9M | $340.3M |
| Total Debt | $341.9M† | $541.1M† |
| Shareholders' Equity | $836.6M | $902.3M |
| Retained Earnings | -$433.8M | -$325.8M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $5.23M | $7.02M |
| CapEx | $27.0M | $41.1M |
| Investing Cash Flow | -$12.3M | $12.9M |
| Financing Cash Flow | -$200.3M | $4.65M |
| Free Cash Flow | -$21.8M | -$34.0M |
FAQ
What is NEO P/E and revenue?
NeoGenomics Inc (NEO) rev $727.3M.
What is NEO revenue?
NeoGenomics Inc last cached revenue is $727.3M (FY2025).
Is NEO profitable?
NeoGenomics Inc last cached net income is -$108.0M (FY2025).
What are NEO total assets?
NeoGenomics Inc last cached total assets are $1.36B (FY2025).
What is NEO free cash flow?
NeoGenomics Inc last cached free cash flow is -$21.8M (FY2025).
Not investment advice. Cached statements, not a live tape.